挽救性喉切除术后的失败模式及预后因素分析
本研究回顾性分析147例放疗(±化疗)后复发或持续存在的喉鳞癌患者,接受挽救性喉切除术后的失败模式及预后因素。2年局部区域失败率为21.8%,总生存率为65%。多因素分析显示肉瘤样/梭形细胞病理、淋巴血管间隙侵犯(LVSI)和初始晚期分期与无病生存期较差独立相关。结论提示多数患者挽救性手术后局部区域控制良好,应审慎考虑常规术后再放疗或全身治疗强化。
要点
- 挽救性喉切除术后2年局部区域失败率21.8%,总生存率65%。
- 肉瘤样病理、LVSI和初始III-IVB期与较差无病生存独立相关。
- 多数患者挽救性手术后控制良好,常规治疗强化需谨慎。
核心结论
- 挽救性喉切除术后多数患者可获得成功的局部区域控制和生存。
- 肉瘤样病理、LVSI和初始晚期分期与较差的无病生存独立相关。
- 这些因素的存在可能值得进一步研究术后治疗强化。
研究设计与样本
- 回顾性分析,来自三级学术转诊中心的头颈癌登记数据库。
- 连续纳入147例1995年5月至2016年5月间因放疗(±化疗)后复发或持续存在而接受挽救性喉切除术的鳞状细胞癌患者。
主要发现
- 预计2年局部区域失败率为21.8%(95%CI 14.6%-29.0%)。
- 总生存率为65%(95%CI 57.5%-74.3%)。
- 多因素分析显示肉瘤样/梭形细胞病理(HR 3.147;95%CI 1.181-8.386;P=0.022)与较差无病生存独立相关。
- LVSI阳性与阴性相比(HR 2.31;95%CI 1.21-4.42;P=0.011)与较差无病生存独立相关。
- 初始AJCC第7版分期III-IVB期与I-II期相比(HR 1.64;95%CI 1.04-2.6;P=0.035)与较差无病生存独立相关。
临床怎么用
- 对于大多数挽救性喉切除术后患者,不应常规进行术后再放疗或全身治疗强化。
- 存在肉瘤样病理、LVSI或初始晚期分期的患者可考虑进一步研究治疗强化。
局限性
- 回顾性研究设计。
- 证据等级为4级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE/HYPOTHESIS: There are limited treatment options beyond surgical salvage for patients who fail nonoperative treatment for laryngeal squamous cell carcinoma. In this study, we examine the failure patterns after surgical salvage and the potential pathologic and clinical prognostic variables that might guide further postoperative intensification investigation. STUDY DESIGN: Retrospective analysis at a tertiary academic referral center. METHODS: From an institutional review board-approved institutional head and neck cancer registry, a consecutive series of 147 patients who underwent salvage laryngectomy for squamous cell cancer recurrence or persistence after radiotherapy with or without chemotherapy between May 1995 and May 2016 were identified. Variables potentially associated with oncologic outcome after surgical salvage were then collected and retrospectively evaluated. RESULTS: The projected 2-year locoregional failure rate was 21.8% (95% confidence interval [CI], 14.6%-29.0%]), and the overall survival 65% (95% CI, 57.5%-74.3%) for the entire cohort after salvage laryngectomy. On multivariable analysis, sarcomatoid/spindle cell pathology (hazard ratio [HR], 3.147; 95% CI, 1.181-8.386; P = 0.022), lymphovascular space invasion (LVSI) (positive vs. negative; HR, 2.31; 95% CI, 1.21-4.42; P = 0.011), and advanced initial American Joint Committee on Cancer 7th Edition grouped stage (stages III-IVB vs. stages I-II; HR, 1.64; 95% CI, 1.04-2.6; P = 0.035) were found to be independently associated with inferior disease-free survival. No other clinical or pathologic variables predicted failure. CONCLUSION: Salvage laryngectomy after nonoperative treatment failure results in successful locoregional control rates and survival in the majority of patients failing initial therapy. This should temper enthusiasm for routine treatment intensification with postoperative re-irradiation and/or other systemic treatments for the vast majority of patients. Sarcomatoid pathology, LVSI, and an advanced initial stage are associated with inferior disease-free survival. The presence of these factors may warrant further investigational study of treatment intensification after salvage laryngectomy. LEVEL OF EVIDENCE: 4. Laryngoscope, 128:823-830, 2018.
引用
- Scharpf J, Ward M, Adelstein D, et al. Elucidation of salvage laryngectomy pathologic and clinical variables to guide further treatment intensification investigation. Laryngoscope. 2017. PMID: 28891087. doi:10.1002/lary.26782
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。